Contineum Therapeutics, Inc. (CTNM) insider trading

Over the last 12 months, 0 insiders bought $0 and 3 insiders sold $1.86M of Contineum Therapeutics, Inc. stock on the open market, according to SEC Form 4 filings.

Latest insider buys and sells

Which funds own Contineum Therapeutics, Inc.